Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Mycotoxin Testing
... CAGR of 5.9% over the analysis period 2024-2030. Spectroscopy- & Chromatography-Based, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Malaria Diagnostics
... CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the ... Read More
-
Multiplex Detection Immunoassays
... at a CAGR of 3.4% over the analysis period 2024-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Billion by the end ... Read More
-
Nucleic Acid Labeling
... at a CAGR of 7.5% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Oncology Molecular Diagnostics
... at a CAGR of 11.1% over the analysis period 2024-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Bio-MEMS Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis ... Read More
-
Laboratory Benchtop Automation
... at a CAGR of 4.8% over the analysis period 2024-2030. Pharma & Biotech Companies, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Immunofluorescence Assays
... CAGR of 4.4% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the analysis period. ... Read More
-
Breast Cancer Screening
... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Cardiopulmonary Autotransfusion Systems
... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More
-
Enteric Disease Testing
... at a CAGR of 4.8% over the analysis period 2024-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Heparin
... 2.8% over the analysis period 2024-2030. Low Molecular Weight Heparin (LMWH), one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$5.9 Billion by the end of the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Hyperspectral Imaging Systems
... at a CAGR of 18.7% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$53.0 Billion by the end of the ... Read More
-
RSV Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$686.6 Million by the end of the ... Read More
-
POC Lipid Testing
... at a CAGR of 3.2% over the analysis period 2024-2030. Hyperlipidemia, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$97.0 Million by the end of the ... Read More
-
Drug Screening
... CAGR of 16.7% over the analysis period 2024-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$16.7 Billion by the end of the ... Read More
-
Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034
... the initiation of heparin therapy. It is primarily caused by the formation of antibodies against platelet factor 4 (PF4) and heparin. The diagnosis of Heparin-induced thrombocytopenia is based on a combination of clinical assessment, laboratory ... Read More
-
ELISpot and FluoroSpot Assay
... 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$464.4 Million by the ... Read More
-
Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT)
... (CBCT) estimated at US$3.1 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Orthopedics, one of the segments analyzed in ... Read More
-
Glucose Biosensors
... CAGR of 2.1% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Medical Cyclotron
... CAGR of 10.6% over the analysis period 2024-2030. 16-18 MeV, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$317.8 Million by the end of the analysis ... Read More
-
MRI-Guided Neurosurgical Ablation
... at a CAGR of 6.7% over the analysis period 2024-2030. RF Ablation Systems, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$301.7 Million by the end ... Read More
-
Next Generation Cancer Diagnostics
... 2030, growing at a CAGR of 21.8% over the analysis period 2024-2030. qPCR & Multiplexing, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$28.2 Billion by ... Read More
Research Assistance
